Augmented levels of CD44 in macrophages from atherosclerotic subjects: a possible IL-6-CD44 feedback loop?

Daniel Hägg1, Sara Sjöberg, Lillemor Mattsson Hultén

  • 1Research Center for Endocrinology and Metabolism, Department of Metabolism and Cardiovascular Research, Göteborg, Sweden.

Atherosclerosis
|April 20, 2006
PubMed

Insights

Elevated CD44 levels in macrophages are linked to atherosclerosis. Interleukin-6 (IL-6) and CD44 form a feedback loop, potentially worsening this cardiovascular disease.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Biology

Background:

  • The cell-adhesion molecule CD44 is implicated in atherosclerosis.
  • Pro-inflammatory cytokines are known to influence CD44 expression.

Purpose of the Study:

  • To investigate the role of elevated CD44 levels in human macrophages within the context of atherosclerosis.
  • To explore the relationship between CD44 expression, genetic factors, and cytokine levels in atherosclerotic subjects.

Main Methods:

  • Compared CD44 transcript and protein levels in macrophages from atherosclerotic subjects versus controls.
  • Analyzed single nucleotide polymorphisms in the CD44 gene for association with coronary artery disease.
  • Examined correlations between plasma cytokine levels and CD44 expression.
  • Investigated IL-6 levels in CD44-deficient mice and the effect of IL-6 on CD44 expression in human macrophages.

Main Results:

  • Macrophages from atherosclerotic subjects exhibited significantly elevated CD44 transcript and protein levels.
  • No association was found between analyzed CD44 gene polymorphisms and coronary artery disease.
  • Elevated CD44 expression in atherosclerotic subjects correlated with increased IL-6 secretion.
  • CD44-deficient mice showed reduced circulating IL-6 levels.
  • IL-6 was found to augment CD44 expression in human macrophages over time.

Conclusions:

  • A positive feedback loop exists between IL-6 and CD44 in macrophages.
  • This IL-6-CD44 feedback loop may contribute to the progression of atherosclerosis.